George Chamoun - 07 Mar 2025 Form 4 Insider Report for ACV Auctions Inc. (ACVA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
11 Mar 2025, 16:27:56 UTC
Prior SEC filing
06 Mar 2025
Next SEC filing
21 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michelle Webb, Attorney-in-Fact

Key filing fact

George Chamoun filed Form 4 for ACV Auctions Inc. (ACVA) on 11 Mar 2025.

Key facts

  • This page summarizes George Chamoun's Form 4 filing for ACV Auctions Inc. (ACVA).
  • 6 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 11 Mar 2025, 16:27.

Change

  • Previous filing in this sequence was filed on 06 Mar 2025.
  • Current net transaction value: +$490,849.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ACVA transaction

Class A Common Stock

Options Exercise

Transaction value
$42,000
Shares
+300,000
Change %
+12%
Price
$0.1400
Shares after
2,901,048
Date
07 Mar 2025
Ownership
Direct
ACVA transaction

Class A Common Stock

Award

Transaction value
$787,314
Shares
+41,156
Change %
+1.4%
Price
$19.13
Shares after
2,942,204
Date
07 Mar 2025
Ownership
Direct
Footnotes
F1
ACVA transaction

Class A Common Stock

Tax liability

Transaction value
$296,465
Shares
-21,011
Change %
-0.71%
Price
$14.11
Shares after
2,921,193
Date
07 Mar 2025
Ownership
Direct
Footnotes
F2
ACVA transaction

Class A Common Stock

Options Exercise

Transaction value
$35,000
Shares
+250,000
Change %
+8.6%
Price
$0.1400
Shares after
3,171,193
Date
10 Mar 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ACVA transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value
$42,000
Shares
-300,000
Change %
-31%
Price
$0.1400
Shares after
652,730
Date
07 Mar 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
300,000
Exercise price
$0.1400
Footnotes
F3
ACVA transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value
$35,000
Shares
-250,000
Change %
-38%
Price
$0.1400
Shares after
402,730
Date
10 Mar 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
250,000
Exercise price
$0.1400
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Grant of Restricted Stock Units issued pursuant of the Company's 2024 Target Bonus Program whereby targets defined by the Compensation Committee were deemed to be achieved by the Board of Directors for the fiscal year 2024. The RSUs vested 100% upon grant on March 7, 2025.

Footnote F2

These shares were withheld by the Issuer to cover the tax liability upon the immediate vesting of the restricted stock unit granted and does not represent a discretionary sale by the reporting person.

Footnote F3

One-fourth (1/4th) of the shares subject to the option award vested on March 22, 2018, and thereafter one-forty-eighth of the shares subject to the option award vested monthly, subject to the Reporting Person's continuous service.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .